Eli Lilly aims to treat equal numbers of patients in LMICs and high-income countries by 2040
LLY•Eli Lilly aims to treat equal numbers of patients in low- and middle-income countries and high-income countries by 2040. The company plans to register diabetes and obesity medicines in LMICs and expand access.
1. Access goals
Eli Lilly said it aims to treat equal numbers of patients in low- and middle-income countries and high-income countries by 2040. It plans to register diabetes and obesity medicines in LMICs and expand access.
